[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20080413T3 - Medicament for the treatment of fungal infections, particularly aspergillosis - Google Patents

Medicament for the treatment of fungal infections, particularly aspergillosis

Info

Publication number
HRP20080413T3
HRP20080413T3 HR20080413T HRP20080413T HRP20080413T3 HR P20080413 T3 HRP20080413 T3 HR P20080413T3 HR 20080413 T HR20080413 T HR 20080413T HR P20080413 T HRP20080413 T HR P20080413T HR P20080413 T3 HRP20080413 T3 HR P20080413T3
Authority
HR
Croatia
Prior art keywords
medicament
treatment
fungal infections
aspergillosis
particularly aspergillosis
Prior art date
Application number
HR20080413T
Other languages
English (en)
Croatian (hr)
Inventor
Salvatori Giovanni
Carminati Paolo
Romani Luigina
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of HRP20080413T3 publication Critical patent/HRP20080413T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
HR20080413T 2004-05-07 2008-08-26 Medicament for the treatment of fungal infections, particularly aspergillosis HRP20080413T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
PCT/IT2005/000247 WO2005107791A1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis

Publications (1)

Publication Number Publication Date
HRP20080413T3 true HRP20080413T3 (en) 2008-10-31

Family

ID=34968212

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080413T HRP20080413T3 (en) 2004-05-07 2008-08-26 Medicament for the treatment of fungal infections, particularly aspergillosis

Country Status (25)

Country Link
US (2) US8778389B2 (xx)
EP (1) EP1750744B1 (xx)
JP (1) JP5574565B2 (xx)
KR (1) KR101192611B1 (xx)
CN (1) CN1950104B (xx)
AR (1) AR048775A1 (xx)
AT (1) ATE397937T1 (xx)
AU (1) AU2005239913B2 (xx)
BR (1) BRPI0510718A (xx)
CA (1) CA2563400C (xx)
CY (1) CY1108332T1 (xx)
DE (1) DE602005007485D1 (xx)
DK (1) DK1750744T3 (xx)
ES (1) ES2306145T3 (xx)
HK (1) HK1103961A1 (xx)
HR (1) HRP20080413T3 (xx)
IT (1) ITRM20040223A1 (xx)
ME (1) ME02743B (xx)
MX (1) MXPA06012889A (xx)
PL (1) PL1750744T3 (xx)
PT (1) PT1750744E (xx)
RS (1) RS50591B (xx)
SI (1) SI1750744T1 (xx)
TW (1) TWI393569B (xx)
WO (1) WO2005107791A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ITMI20062448A1 (it) * 2006-12-19 2008-06-20 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio dell¿ aspergillosi invasiva
US8838152B2 (en) 2007-11-30 2014-09-16 Microsoft Corporation Modifying mobile device operation using proximity relationships
CN101280326B (zh) * 2008-05-14 2011-07-06 中国科学院微生物研究所 一种抑制烟曲霉活性的化合物制备方法及其应用
US20150299277A1 (en) * 2012-06-22 2015-10-22 The University Of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
EP3803396B1 (en) * 2018-06-01 2023-03-01 B.R.A.H.M.S GmbH Biomarkers for the diagnosis of invasive fungal infections
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections
CN113952401B (zh) * 2021-12-15 2022-10-25 河北农业大学 一种用于防治畜禽曲霉菌感染的中药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP2001183375A (ja) 1999-12-27 2001-07-06 Tosoh Corp 酵素標識抗体
WO2005026195A1 (en) * 2003-09-12 2005-03-24 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis
EP1730095A4 (en) * 2004-03-29 2008-04-02 Univ Mississippi NEW CYCLOPENTENDION COMPOUNDS ACTING AGAINST MUSHROOMS AND METHOD FOR THEIR APPLICATION
ITRM20040489A1 (it) 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8337828B2 (en) 2006-05-02 2012-12-25 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

Also Published As

Publication number Publication date
DE602005007485D1 (de) 2008-07-24
JP2007536380A (ja) 2007-12-13
ITRM20040223A1 (it) 2004-08-07
DK1750744T3 (da) 2008-09-29
EP1750744A1 (en) 2007-02-14
CN1950104B (zh) 2010-11-10
ME02743B (me) 2010-05-07
CA2563400A1 (en) 2005-11-17
US8778389B2 (en) 2014-07-15
CA2563400C (en) 2013-07-30
PL1750744T3 (pl) 2008-11-28
HK1103961A1 (en) 2008-01-04
ES2306145T3 (es) 2008-11-01
US20080026997A1 (en) 2008-01-31
EP1750744B1 (en) 2008-06-11
KR20070007375A (ko) 2007-01-15
JP5574565B2 (ja) 2014-08-20
US20140296135A1 (en) 2014-10-02
TW200602075A (en) 2006-01-16
WO2005107791A1 (en) 2005-11-17
CY1108332T1 (el) 2014-02-12
AR048775A1 (es) 2006-05-24
BRPI0510718A (pt) 2007-11-20
RS50591B (sr) 2010-05-07
AU2005239913B2 (en) 2011-08-18
KR101192611B1 (ko) 2012-10-18
PT1750744E (pt) 2008-08-14
CN1950104A (zh) 2007-04-18
TWI393569B (zh) 2013-04-21
ATE397937T1 (de) 2008-07-15
AU2005239913A1 (en) 2005-11-17
SI1750744T1 (sl) 2008-10-31
MXPA06012889A (es) 2007-02-15

Similar Documents

Publication Publication Date Title
HRP20080413T3 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
TR201906789T4 (tr) Üretim ve enjeksiyon cihazlarında kullanım için en uygun olan propilen glikol ihtiva eden peptit formülasyonları.
CL2007001749A1 (es) Compuesto derivado de 2-arilamino-4-(heterociclo)aminopirimidina, inhibidores de la proteina quinasa c-alfa; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes, cancer, enfermedad cardiaca coronaria, aterosclerosis, entre otras.
WO2005055973A3 (de) Endoparasitizide mittel zur topischen applikation
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
BRPI0922435A2 (pt) "composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
WO2010009892A8 (en) Compositions for the treatment of pain and/or inflamation
BRPI0815578A2 (pt) Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo.
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
TNSN07240A1 (en) Compounds for flaviviridae treatment
DE60312211D1 (de) Haarbehandlungsmittel
UY28344A1 (es) Nuevos compuestos
CL2008001322A1 (es) Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
BRPI0500536A (pt) Composição antimicrobiana
ATE399532T1 (de) Medizinische seife
NO20075277L (no) Rekombinant uttrykking av defensiner i filamentose sopper
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
CR9270A (es) Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales
FR2892921B1 (fr) Injecteur d'implant ophtalmique.